| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000011938 |
| Receipt No. | R000013939 |
| Official scientific title of the study | Granulocyte colony-stimulating factor-mediated neuroprotective therapy for acute aggravation of cervical compressive myelopathy: multicenter placebo controlled randomized single blinded trial. |
| Date of disclosure of the study information | 2013/10/04 |
| Last modified on | 2019/03/07 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Granulocyte colony-stimulating factor-mediated neuroprotective therapy for acute aggravation of cervical compressive myelopathy: multicenter placebo controlled randomized single blinded trial. | |
| Title of the study (Brief title) | Granulocyte colony-stimulating factor-mediated neuroprotective therapy for acute aggravation of cervical compressive myelopathy: multicenter placebo controlled randomized single blinded trial. | |
| Region |
|
|
| Condition | ||
| Condition | cervical compressive myelopathy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To elucidate the efficacy of granulocyte colony-stimulating factor-mediated neuroprotective therapy for acute aggravation of cervical compressive myelopathy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Attenuation of functional impairment 2 weeks after the drug administration using Japanese Orthopedic Association Cervical Myelopathy Evaluation Score (JOA score). |
| Key secondary outcomes | Attenuation of motor paralysis (ASIA motor score), attenuation of sensory paralysis (ASIA sensory score), attenuation of quality of life (EQ-5D), spinal cord MRI |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Granulocyte colony-stimulating factor | |
| Interventions/Control_2 | normal saline | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Acute aggravation of cervical compressive myelopathy (who showed 2 pts. deterioration of JOA score within 1 month), patients with the voluntary consent documents upon participation, patients who can visit the hospital for one year | |||
| Key exclusion criteria | allergy for G-CSF, history of the malignancy of hematopoietic system, history of malignancy within 5 years, thoromboembolism, splenomegaly, disturbance of consciousness, pregnancy | |||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Takeo Furuya |
| Organization | Chiba University Graduate School of Medicine |
| Division name | Department of Orthopedics |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba |
| TEL | 043-226-2961 |
| takeo251274@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Yukiko Matsumoto |
| Organization | Chiba University Graduate School of Medicine |
| Division name | Department of Orthopedics |
| Address | 1-8-1 Inohana, Chuo-ku, Chiba |
| TEL | 043-226-2961 |
| Homepage URL | |
| chibaseikei8f@yahoo.co.jp | |
| Sponsor | |
| Institute | Department of Orthopedic Surgery, Chiba University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 千葉大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013939 |